USP7 inhibitors (Schrodinger/WuXi AppTec)

N/A

Report date: 2025/03/20 09:46:11
NME

Base Information

Drug NameUSP7 inhibitors (Schrodinger/WuXi AppTec)
Drug Alias Nameubiquitin-specific-processing protease 7 inhibitors (Schrodinger/WuXi AppTec)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 7 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 7
Therapy Area/IndicationsMultiple MyelomaLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger IncWuxi Apptec(Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A